Written Question·Department of Health and Social Care·UIN 107842

Blood Cancer: Medical Treatments

Tabled: 22 January 2026
Answered: 28 January 2026
Named Day

Question

Samantha Niblett

LabourSouth Derbyshire

To ask the Secretary of State for Health and Social Care, whether he has had discussions with NICE on its Final Draft Guidance which does not recommend CAR-T therapy for relapsed or refractory Mantle Cell Lymphoma.

Answer

Dr Zubir Ahmed
Department officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE), including in relation to the development of guidance on individual products.NICE develops its recommendations on new ...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 107842) →

Blood Cancer: Medical Treatments — Written Question | TrustPolitics